莱茵生物：美国印州工厂于今年已升级改造为综合提取工厂，但仍具备CBD的提取能力

Group 1 - The core point of the article is that Rhine Biotech (002166.SZ) has upgraded its factory in Indiana, USA, to a comprehensive extraction facility while still maintaining its capability for CBD extraction [1] Group 2 - The upgrade of the Indiana facility indicates a strategic move by the company to enhance its operational capabilities in the extraction sector [1] - The company continues to focus on CBD extraction, which suggests a commitment to this segment of the market [1]